AKI Therapeutics A/S
CVR 37509736 · Public limited company (A/S) · Active · Medium risk
AKI Therapeutics A/S is a Public limited company (A/S), founded on , based in Hørsholm. The company is registered in the industry fremstilling af farmaceutiske præparater. Our model estimates a bankruptcy risk of 1.6% over the next 12 months, which is 1.1 times the average for Danish companies. 10 annual reports have been published, of which 1 more than six months after the end of the financial year. CEO: Sigbjørn Georg Nielsen Kjærgård.
Bankruptcy risk for AKI Therapeutics A/S
1.1 × the average (1.41%) · higher risk than 79% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 37509736
- Status
- Active
- Company type
- Public limited company (A/S)
- Founded
- (10 years)
- Address
- Slotsmarken 12, 1. th
2970 Hørsholm - Municipality
- Hørsholm
- Industry
- Fremstilling af farmaceutiske præparater (212000)
Bankruptcies in the industry: Fremstilling af farmaceutiske præparater - Share capital
- DKK 675k
- Auditor
- Grant Thornton, Godkendt Revisionspartnerselskab
- Audit opted out
- No
Warning signs
| Annual reports filed late | 1 of 10 |
| Missing annual report | No |
| Negative equity | – |
| Equity ratio | – |
| Current ratio | – |
| Moves (last 2 years) | 0 |
| CEO changes in total | 3 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 58 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Revenue | – | DKK 0 | DKK 0 |
| Net profit | – | DKK -2.0m | DKK -1.7m |
| Equity | – | DKK 807k | DKK 747k |
| Total assets | – | DKK 2.2m | DKK 2.0m |
| Cash | – | DKK 104k | – |
Latest annual report: Reporting class C, mellemstor virksomhed · auditor's statement: Auditor's report on audited financial statements · Grant Thornton, Godkendt Revisionspartnerselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 160 | ||
| 1 Jan 2024 – 31 Dec 2024 | 181 | ||
| 1 Jan 2023 – 31 Dec 2023 | 170 | ||
| 1 Jan 2022 – 31 Dec 2022 | 153 | ||
| 1 Jan 2021 – 31 Dec 2021 | 153 | ||
| 1 Jan 2020 – 31 Dec 2020 | 174 | ||
| 1 Jan 2019 – 31 Dec 2019 | 245 | Late | |
| 1 Jan 2018 – 31 Dec 2018 | 177 | ||
| 1 Jan 2017 – 31 Dec 2017 | 160 | ||
| 1 Mar 2016 – 31 Dec 2016 | 160 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Sigbjørn Georg Nielsen Kjærgård | Current | |
| CEO | Peter Andreas Stakemann | ||
| CEO | Torsten Bjørn | ||
| Board | Christian Vinding Thomsen | Current | |
| Board | Lars Otto Uttenthal | Current | |
| Board | Charlotte Pahl | Current | |
| Board | Troels Peter Troelsen | ||
| Board | Troels Ring | ||
| Owner (10%) | Beier Holding ApS | Current | |
| Owner (5%) | NIELS ERIK JESPERSEN HOLDING ApS | Current | |
| Owner (5%) | BREGNERØDVEJ AUTO ApS | Current | |
| Owner (5%) | FINANSMANAGEMENT ApS | Current | |
| Owner (15%) | DMZ HOLDING ApS | Current | |
| Owner (5%) | Klaus Poulsen Holding ApS | Current | |
| Owner (100%) | SAX FINANS ApS | ||
| Owner (50%) | TT 1919 ApS | ||
| Owner (50%) | SAX FINANS ApS | ||
| Owner (33%) | SAX FINANS ApS | ||
| Owner (10%) | AQ2 A/S | ||
| Owner (25%) | SAX FINANS ApS | ||
| Owner (33%) | TT 1919 ApS | ||
| Owner (15%) | FINANSMANAGEMENT ApS | ||
| Owner (5%) | VULKAN INVEST ApS | ||
| Owner (5%) | TP INVEST DK ApS | ||
| Owner (20%) | TT 1919 ApS | ||
| Owner (20%) | SAX FINANS ApS | ||
| Owner (20%) | FINANSMANAGEMENT ApS | ||
| Owner (15%) | TT 1919 ApS | ||
| Owner (10%) | SAX FINANS ApS | ||
| Owner (10%) | J.K.C. HOLDING ApS | ||
| Owner (10%) | TT 1919 ApS | ||
| Owner (5%) | FINANSMANAGEMENT ApS | ||
| Owner (5%) | TT 1919 ApS | ||
| Owner (5%) | SAX FINANS ApS | ||
| Owner (10%) | FINANSMANAGEMENT ApS | ||
| Owner (5%) | J.K.C. HOLDING ApS | ||
| Owner (5%) | DMZ HOLDING ApS | ||
| Owner (10%) | DMZ HOLDING ApS | ||
| Auditor | Grant Thornton, Godkendt Revisionspartnerselskab | Current | |
| Auditor | KALLERMANN REVISION A/S STATSAUTORISERET REVISIONSFIRMA | ||
| Founder | ApS KBURS 17 NR. 6919 | Current |
The CEOs' other companies
Sigbjørn Georg Nielsen Kjærgård – 8 other companies, of which 1 bankrupt
- Science Academy ApS Bankrupt 14 May 2024
- ACTION PHARMA HOLDING I A/S Opløst
- GYNZONE ApS Active
- NORDIC BIOTECH HOLDING ApS Active
- REPOCEUTICALS A/S Active
- REPONEX PHARMACEUTICALS A/S Active
- SELSKABET AF 20.02.2002 ApS Opløst
- SYNACT PHARMA ApS Active
Peter Andreas Stakemann – 54 other companies, of which 54 bankrupt
- 01-05-24 ApS Bankrupt 17 Mar 2025
- 061746M A/S Bankrupt 3 Oct 2011
- 1 STEP, COPENHAGEN LOGISTIC & DISTRIBUTION ApS Bankrupt 15 Jan 2009
- 1001 WATT ApS Bankrupt 29 Jan 2002
- 123 AF 04.07.2012 ApS Bankrupt 6 Aug 2012
- 1264 ApS Bankrupt 12 Jun 2012
- 1414 EJENDOMSINVEST 10 ApS Bankrupt 22 Dec 2015
- 1414 EJENDOMSINVEST 12 ApS Bankrupt 22 Dec 2015
- 1414 EJENDOMSINVEST ApS Bankrupt 19 Dec 2014
- 1414 INVEST ApS Bankrupt 22 Dec 2015
- 1WAY2PRINT A/S Bankrupt 24 Jul 2003
- 2 X KJAER DK ApS Bankrupt 18 Dec 2024
- 20220608 ApS Bankrupt 18 Jul 2022
- 23K ApS Bankrupt 17 Jan 2022
- 24237982 A/S Bankrupt 25 Apr 2012
- 2BU EJENDOMME ApS Bankrupt 11 Sep 2013
- 2BU HOLDING ApS Bankrupt 2 Oct 2013
- 2Tal enterprise A/S Bankrupt 28 Apr 2020
- 2V AMAGER SYD ApS Bankrupt 20 Dec 2000
- 3 SIGMA ApS Bankrupt 9 Jun 2005
- 30 08 61 71 ApS Bankrupt 1 Dec 2011
- 31. OKTOBER 2008 ApS Bankrupt 18 Sep 2009
- 32 67 71 93 ApS Bankrupt 16 Nov 2011
- 36087374 ApS Bankrupt 10 Jan 2017
- 365 Service Holding ApS Bankrupt 26 Nov 2020
- 365 Service Partner ApS Bankrupt 26 Nov 2020
- 39701804 ApS Bankrupt 14 Aug 2020
- 39704994 ApS Bankrupt 14 Aug 2020
- 3BH ApS Bankrupt 3 May 2019
- 3XE BYG ApS Bankrupt 11 Aug 2017
Torsten Bjørn – 21 other companies, of which 2 bankrupt
- NATURAL MEDICO TECH ApS Bankrupt 26 Nov 2010
- VICH 3955 ApS Bankrupt 17 Oct 1996
- AQUA-WALL DANMARK A/S Fusioneret
- BIOPORTO DIAGNOSTICS A/S Active
- DKA CONSULT ApS Opløst
- DKA EJENDOMME ApS Opløst
- Geysir Holding ApS Active
- Geysir Invest ApS Active
- NORDIC BIOTECH HOLDING ApS Active
- Nordic Pharma Lab ApS Active
- Nordic Science Group ApS Active
- REPOCEUTICALS A/S Active
- REPONEX PHARMACEUTICALS A/S Active
- REPOS PHARMA ApS Opløst
- SAX FINANS ApS Active
- SCHWANEBECK VERWALTUNG ZWEI ApS Opløst
- SPONSOR SUPPORT ApS Compulsorily dissolved
- SPRINGE/GESTORF VERWALTUNG ApS Active
- Serenova A/S Opløst
- VICTOR & FABIAN ApS Compulsorily dissolved
- VULKAN INVEST ApS Active
Address history (2 moves)
| Slotsmarken 12, 1. th, 2970 Hørsholm | |
| Ørumgårdsvej 1E, 3490 Kvistgård | |
| Kronprinsessegade 18, 1306 København K |
Former names
| AKI Therapeutics A/S | – now |
| AKI Therapeutics ApS | – |
| Renoguard ApS | – |
| ApS STM nr. 4310 | – |
Other companies at the same address
- CVIP ApS Bankrupt
- CVIP HOLDING ApS Bankrupt
- HI AF 26/11-2010 A/S Bankrupt
- Liquid Wind Denmark ApS Bankrupt
- A/S CRYSTINOL Fusioneret
- ApS KBUS 17 NR. 4807 Opløst
- ApS KBUS 38 NR. 1027 Opløst
- Aurea Kapital ApS Active
- BIOPHARMA HOLDING ApS Opløst
- BLANKAMI ApS Opløst
- CAMBRIDGE TECHNOLOGY PARTNERS A/S Opløst
- DKA ADMINISTRATION ApS Opløst
- DKA CONSULT ApS Opløst
- DKA EJENDOMME ApS Opløst
- DKA FINANS ApS Opløst
- DKA INVEST ApS Opløst
- EXPANDIT DEVELOPMENT ApS Active
- EXPANDIT HOLDING A/S Active
- EXPANDIT INTERNATIONAL A/S Active
- EXPANDIT MOBILE ApS Active
- EXPANDIT UTILITIES ApS Opløst
- Erestas ApS Active
- FACET 4 ApS Compulsorily dissolved
- FINANSMANAGEMENT 2 ApS Opløst
- FINANSMANAGEMENT 3 ApS Opløst
Similar companies in Hørsholm
- PeriOp Innovations ApS Hørsholm
- Nordic Science Group ApS Hørsholm
- Nordic Pharma Lab ApS Hørsholm
- Afyx Therapeutics A/S Hørsholm
- REPOCEUTICALS A/S Hørsholm
- CONRIG PHARMA ApS Vedbæk
- REPONEX PHARMACEUTICALS A/S Hørsholm
- RB af 31-5-2018 ApS Hørsholm
- Netto Medicin IVS Rungsted Kyst
- Footprint Pharma ApS Hørsholm
- REPOS PHARMA ApS Hørsholm
Questions and answers about AKI Therapeutics A/S
Has AKI Therapeutics A/S gone bankrupt?
No, AKI Therapeutics A/S is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of AKI Therapeutics A/S?
Our model estimates a bankruptcy risk of 1.6% over the next 12 months (medium risk), which is 1.1 times the average for Danish companies.
Who is the CEO of AKI Therapeutics A/S?
Sigbjørn Georg Nielsen Kjærgård is the CEO of AKI Therapeutics A/S.
Who is the auditor of AKI Therapeutics A/S?
AKI Therapeutics A/S most recently used Grant Thornton, Godkendt Revisionspartnerselskab.
When was AKI Therapeutics A/S founded?
AKI Therapeutics A/S was founded on 1 March 2016.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.